Premium
PK and PD of escalating, single IV doses of a synthetic allosteric hemoglobin (Hb) modifier, RSR13, in patients with stable effort angina
Author(s) -
Venitz J.,
Liard J.F.,
Hackman J.
Publication year - 1999
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(99)80134-9
Subject(s) - allosteric regulation , hemoglobin , pharmacology , chemistry , medicine , biochemistry , receptor
Clinical Pharmacology & Therapeutics (1999) 65 , 151–151; doi: